{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:18:02Z","timestamp":1793089082354,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.metabol.2021.154915","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T13:41:29Z","timestamp":1634823689000},"page":"154915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure"],"prefix":"10.1016","volume":"125","author":[{"given":"M\u00f2nica","family":"Bull\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Papandreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Garc\u00eda-Gavil\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ruiz-Canela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Guasch-Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Corella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Estruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Fit\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Razquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ar\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Serra-Majem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Mart\u00ednez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Salas-Salvad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154915_bb0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM199711063371906","article-title":"Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities","volume":"337","author":"Braunwald","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154915_bb0010","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154915_bb0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pcad.2005.09.001","article-title":"Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment","volume":"48","author":"Heist","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2021.154915_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond atp production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154915_bb0025","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1253\/circj.CJ-17-1058","article-title":"Metabolic considerations in atrial fibrillation \u2014 mechanistic insights and therapeutic opportunities","volume":"81","author":"Harada","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.metabol.2021.154915_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001606","article-title":"Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons","volume":"11","author":"Fischer","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.metabol.2021.154915_bb0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ehf2.12133","article-title":"Metabolic profiles in heart failure due to non-ischemic cardiomyopathy at rest and under exercise","volume":"4","author":"Mueller-Hennessen","year":"2017","journal-title":"ESC Hear Fail"},{"key":"10.1016\/j.metabol.2021.154915_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmet.2015.06.021","article-title":"Hypoxia-mediated increases in l-2-hydroxyglutarate coordinate the metabolic response to reductive stress","volume":"22","author":"Oldham","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154915_bb0045","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1073\/pnas.1601650113","article-title":"Oncometabolite d-2-hydroxyglutarate impairs \u03b1-ketoglutarate dehydrogenase and contractile function in rodent heart","volume":"113","author":"Karlstaedt","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154915_bb0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1212\/WNL.0000000000006957","article-title":"Succinate links atrial dysfunction and cardioembolic stroke","volume":"92","author":"Nelson","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.metabol.2021.154915_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2021.154915_bb0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ije\/dyq250","article-title":"PREDIMED study investigators cohort profile: design and methods of the PREDIMED study","volume":"41","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2021.154915_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIRCULATIONAHA.113.006921","article-title":"Extra virgin olive oil consumption reduces risk of atrial fibrillation: the PREDIMED (Prevenci\u00f3n con Dieta Mediterr\u00e1nea) trial","volume":"130","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2021.154915_bb0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/ejhf.750","article-title":"Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial","volume":"19","author":"Papadaki","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2021.154915_bb0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/1055-9965.EPI-08-0839","article-title":"A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression","volume":"18","author":"Wang","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2021.154915_bb0080","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2021.154915_bb0085","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154915_bb0090","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/oxfordjournals.aje.a116966","article-title":"Validation of the Minnesota leisure time physical activity questionnaire in Spanish men. The MARATHOM investigators","volume":"139","author":"Elosua","year":"1994","journal-title":"Am J Epidemiol"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2021.154915_bb0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.metabol.2021.154915_bb0100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCGENETICS.114.000220","article-title":"Citric acid cycle intermediates in cardioprotection","volume":"7","author":"Czibik","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"10.1016\/j.metabol.2021.154915_bb0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1365-201x.2000.00717.x","article-title":"Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle","volume":"168","author":"Gibala","year":"2000","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.metabol.2021.154915_bb0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1054\/mehy.2001.1335","article-title":"Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer","volume":"57","author":"John","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.metabol.2021.154915_bb0115","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"Hansel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154915_bb0120","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00216-009-2610-6","article-title":"Plasma fingerprinting with GC\u2013MS in acute coronary syndrome","volume":"394","author":"Vallejo","year":"2009","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.metabol.2021.154915_bb0125","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/pr200452j","article-title":"The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples","volume":"10","author":"Bernini","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2021.154915_bb0130","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1161\/CIRCULATIONAHA.105.569137","article-title":"Metabolomic identification of novel biomarkers of myocardial ischemia","volume":"112","author":"Sabatine","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154915_bb0135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpba.2012.10.029","article-title":"Method based on GC\u2013MS to study the influence of tricarboxylic acid cycle metabolites on cardiovascular risk factors","volume":"74","author":"Calder\u00f3n-Santiago","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.metabol.2021.154915_bb0140","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1039\/b925612a","article-title":"Untargeted metabolic profiling reveals potential biomarkers in myocardial infarction and its application","volume":"6","author":"Yao","year":"2010","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.metabol.2021.154915_bb0145","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart \u2014 an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154915_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-017-0604-9","article-title":"Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes","volume":"16","author":"Karam","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154915_bb0155","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154915_bb0160","doi-asserted-by":"crossref","first-page":"19611","DOI":"10.1073\/pnas.1117773108","article-title":"Hypoxia promotes isocitrate dehydrogenasedependent carboxylation of \u03b1-ketoglutarate to citrate to support cell growth and viability","volume":"108","author":"Wise","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154915_bb0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvx017","article-title":"Metabolism in cardiomyopathy: every substrate matters","volume":"113","author":"Ritterhoff","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154915_bb0170","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1634\/theoncologist.2014-0266","article-title":"Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma","volume":"20","author":"Lombardi","year":"2015","journal-title":"Oncologist."},{"key":"10.1016\/j.metabol.2021.154915_bb0175","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/bio-2020-0131","article-title":"Quantitation of 2-hydroxyglutarate in human plasma via LC-MS\/MS using a surrogate analyte approach","volume":"12","author":"Yin","year":"2020","journal-title":"Bioanalysis."},{"issue":"5","key":"10.1016\/j.metabol.2021.154915_bb0180","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/metabo11050306","article-title":"Glycolysis metabolites and risk of atrial fibrillation and heart failure in the PREDIMED trial","volume":"11","author":"Becerra-Tom\u00e1s","year":"2021","journal-title":"Metabolites."},{"issue":"26","key":"10.1016\/j.metabol.2021.154915_bb0185","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2174\/1381612824666180903125300","article-title":"Mitochondria and the pathophysiological mechanism of atrial fibrillation","volume":"24","author":"Li","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"10","key":"10.1016\/j.metabol.2021.154915_bb0190","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2213-8587(16)30196-6","article-title":"Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521002158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521002158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:29:01Z","timestamp":1758428941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521002158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":38,"alternative-id":["S0026049521002158"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154915","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154915"}}